1 Johansen JW, "Update on bispectral index monitoring" 20 : 81-99, 2006
2 Zanner R, "Time delay of electroencephalogram index calculation: analysis of cerebral state, bispectral, and Narcotrend indices using perioperatively recorded electroencephalographic signals" 103 : 394-399, 2009
3 Shah B, "The changing faces of endoscopic sedation" 4 : 417-422, 2010
4 Jian Wu, "The Influence of the Severity of Chronic Virus-Related Liver Disease on Propofol Requirements during Propofol-Remifentanil Anesthesia" 연세대학교의과대학 54 (54): 231-237, 2013
5 Park CH, "Sedation methods can determine performance of endoscopic submucosal dissection in patients with gastric neoplasia" SPRINGER 27 (27): 2760-2767, 2013
6 Imagawa A, "Satisfaction with bispectral index monitoring of propofol-mediated sedation during endoscopic submucosal dissection: a prospective, randomized study" 40 : 905-909, 2008
7 Külling D, "Safer colonoscopy with patient-controlled analgesia and sedation with propofol and alfentanil" 54 : 1-7, 2001
8 Kiriyama S, "Safe and effective sedation in endoscopic submucosal dissection for early gastric cancer: a randomized comparison between propofol continuous infusion and intermittent midazolam injection" 45 : 831-837, 2010
9 Park CH, "Risk Factors and Prognosis of Pulmonary Complications After Endoscopic Submucosal Dissection for Gastric Neoplasia" SPRINGER 58 (58): 540-546, 2013
10 Bürkle H, "Remifentanil: a novel, short-acting, mu-opioid" 83 : 646-651, 1996
1 Johansen JW, "Update on bispectral index monitoring" 20 : 81-99, 2006
2 Zanner R, "Time delay of electroencephalogram index calculation: analysis of cerebral state, bispectral, and Narcotrend indices using perioperatively recorded electroencephalographic signals" 103 : 394-399, 2009
3 Shah B, "The changing faces of endoscopic sedation" 4 : 417-422, 2010
4 Jian Wu, "The Influence of the Severity of Chronic Virus-Related Liver Disease on Propofol Requirements during Propofol-Remifentanil Anesthesia" 연세대학교의과대학 54 (54): 231-237, 2013
5 Park CH, "Sedation methods can determine performance of endoscopic submucosal dissection in patients with gastric neoplasia" SPRINGER 27 (27): 2760-2767, 2013
6 Imagawa A, "Satisfaction with bispectral index monitoring of propofol-mediated sedation during endoscopic submucosal dissection: a prospective, randomized study" 40 : 905-909, 2008
7 Külling D, "Safer colonoscopy with patient-controlled analgesia and sedation with propofol and alfentanil" 54 : 1-7, 2001
8 Kiriyama S, "Safe and effective sedation in endoscopic submucosal dissection for early gastric cancer: a randomized comparison between propofol continuous infusion and intermittent midazolam injection" 45 : 831-837, 2010
9 Park CH, "Risk Factors and Prognosis of Pulmonary Complications After Endoscopic Submucosal Dissection for Gastric Neoplasia" SPRINGER 58 (58): 540-546, 2013
10 Bürkle H, "Remifentanil: a novel, short-acting, mu-opioid" 83 : 646-651, 1996
11 Sasaki T, "Recommended sedation and intraprocedural monitoring for gastric endoscopic submucosal dissection" 25 (25): 79-85, 2013
12 Sasaki T, "Propofol sedation with bispectral index monitoring is useful for endoscopic submucosal dissection: a randomized prospective phase II clinical trial" 44 : 584-589, 2012
13 Hsieh YH, "Propofol alone versus propofol in combination with meperidine for sedation during colonoscopy" 43 : 753-757, 2009
14 American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists, "Practice guidelines for sedation and analgesia by non-anesthesiologists" 96 : 1004-1017, 2002
15 Bouillon TW, "Pharmacodynamic interaction between propofol and remifentanil regarding hypnosis, tolerance of laryngoscopy, bispectral index, and electroencephalographic approximate entropy" 100 : 1353-1372, 2004
16 Mazanikov M, "Patient-controlled sedation with propofol and remifentanil for ERCP: a randomized, controlled study" 73 : 260-266, 2011
17 Knape JT, "Guidelines for sedation and/or analgesia by non-anaesthesiology doctors" 24 : 563-567, 2007
18 Sugimoto T, "Endoscopic submucosal dissection is an effective and safe therapy for early gastric neoplasms: a multicenter feasible study" 46 : 124-129, 2012
19 Oda I, "Endoscopic submucosal dissection for early gastric cancer: technical feasibility, operation time and complications from a large consecutive series" 17 : 54-58, 2005
20 Imagawa A, "Endoscopic submucosal dissection for early gastric cancer: results and degrees of technical difficulty as well as success" 38 : 987-990, 2006
21 Yamagata T, "Efficacy of propofol sedation for endoscopic submucosal dissection (ESD): assessment with prospective data collection" 50 : 1455-1460, 2011
22 Drake LM, "Efficacy of bispectral monitoring as an adjunct to nurse-administered propofol sedation for colonoscopy: a randomized controlled trial" 101 : 2003-2007, 2006
23 Paspatis GA, "Efficacy of bispectral index monitoring as an adjunct to propofol deep sedation for ERCP: a randomized controlled trial" 41 : 1046-1051, 2009
24 Ki Joo Kang, "Efficacy of Bispectral Index Monitoring for Midazolam and Meperidine Induced Sedation during Endoscopic Submucosal Dissection: A Prospective, Randomized Controlled Study" 거트앤리버 발행위원회 5 (5): 160-164, 2011
25 Dahaba AA, "Different conditions that could result in the bispectral index indicating an incorrect hypnotic state" 101 : 765-773, 2005
26 von Delius S, "Bispectral index monitoring of midazolam and propofol sedation during endoscopic retrograde cholangiopancreatography: a randomized clinical trial (the EndoBIS study)" 44 : 258-264, 2012
27 Bell JK, "Bispectral index monitoring for conscious sedation in intervention: better, safer, faster" 59 : 1106-1113, 2004
28 Lee CK, "Balanced propofol sedation for therapeutic GI endoscopic procedures: a prospective, randomized study" MOSBY-ELSEVIER 73 (73): 206-214, 2011
29 von Delius S, "Auditory evoked potentials compared with bispectral index for monitoring of midazolam and propofol sedation during colonoscopy" 104 : 318-325, 2009
30 Struys MM, "Ability of the bispectral index, autoregressive modelling with exogenous input-derived auditory evoked potentials, and predicted propofol concentrations to measure patient responsiveness during anesthesia with propofol and remifentanil" 99 : 802-812, 2003